Lyell Immunopharma, Inc. — SCHEDULE 13G/A Filings
7 SCHEDULE 13G/A filings on record
This page lists all SCHEDULE 13G/A filings submitted to the SEC by Lyell Immunopharma, Inc. (LYEL), sorted by most recent first. Each row links to the full filing on EdgarLookup. Lyell Immunopharma, Inc. has filed 7 SCHEDULE 13G/A documents with the SEC since 2020. To view all SEC filings by Lyell Immunopharma, Inc., see the full filings list.
All
10-K
10-Q
144
3
4
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0001012975-25-000768 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-112479 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001193125-25-277861 | Nov 12, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-049403 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0001072613-25-000168 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-013912 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0002012383-25-001224 | Feb 5, 2025 | — |